Revenue
2020
2021
2022
2023
2024
2025
Annovis Bio, Inc. (ANVS)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $25.2M | $20.0M | $38.8M | $16.5M | $8.5M | $3.1M | $776,256 |
| Operating expenses | $29.7M | $26.7M | $45.0M | $25.5M | $14.5M | $6.6M | $1.6M |
| Operating income | −$29.7M | −$26.7M | −$45.0M | −$25.5M | −$14.5M | −$6.6M | −$1.6M |
| Net income | −$28.9M | −$24.6M | −$56.2M | −$25.3M | −$14.5M | −$5.5M | −$990,980 |
| Basic EPSper diluted share | -$1.40 | -$2.02 | -$6.23 | -$3.10 | -$1.90 | -$0.87 | -$3.51 |
| Diluted EPSper diluted share | -$1.40 | -$2.31 | -$6.23 | -$3.10 | -$1.90 | -$0.87 | -$3.51 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 20, 2026Form 4 | Hoffman Michael BDirector | BuyCommon Stock | 54.9K | $1.90 | $104.4K | 3.36M |
| May 20, 2026Form 4 | Hoffman Michael BDirector | BuyCommon Stock | 18.8K | $1.80 | $33.9K | 3.31M |
| May 20, 2026Form 4 | Hoffman Michael BDirector | BuyCommon Stock | 2.6K | $1.75 | $4.5K | 3.29M |
| Apr 2, 2026Form 4 | Hoffman Michael BDirector | BuyCommon Stock | 713.8K | $2.10 | $1.50M | 3.29M |
| Dec 8, 2025Form 4 | Hoffman Michael BDirector | BuyCommon Stock | 15.0K | $4.24 | $63.6K | 2.57M |